BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28541457)

  • 1. Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.
    Arnold SLM; Choi R; Hulverson MA; Schaefer DA; Vinayak S; Vidadala RSR; McCloskey MC; Whitman GR; Huang W; Barrett LK; Ojo KK; Fan E; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC
    J Infect Dis; 2017 Jul; 216(1):55-63. PubMed ID: 28541457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.
    Hulverson MA; Choi R; Arnold SLM; Schaefer DA; Hemphill A; McCloskey MC; Betzer DP; Müller J; Vidadala RSR; Whitman GR; Rivas KL; Barrett LK; Hackman RC; Love MS; McNamara CW; Shaughnessy TK; Kondratiuk A; Kurnick M; Banfor PN; Lynch JJ; Freiberg GM; Kempf DJ; Maly DJ; Riggs MW; Ojo KK; Van Voorhis WC
    Int J Parasitol; 2017 Oct; 47(12):753-763. PubMed ID: 28899690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
    J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
    Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
    J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite Cryptosporidium.
    Arnold SLM; Choi R; Hulverson MA; Whitman GR; Mccloskey MC; Dorr CS; Vidadala RSR; Khatod M; Morada M; Barrett LK; Maly DJ; Yarlett N; Van Voorhis WC
    J Infect Dis; 2019 Aug; 220(7):1188-1198. PubMed ID: 31180118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
    J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
    Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in
    Ajiboye J; Uldry AC; Heller M; Naguleswaran A; Fan E; Van Voorhis WC; Hemphill A; Müller J
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473953
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
    Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy.
    Blanco-García E; Guerrero-Callejas F; Blanco-Méndez J; Gómez-Couso H; Luzardo-Álvarez A
    Eur J Pharm Sci; 2016 Sep; 92():74-85. PubMed ID: 27381880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice.
    Anghel N; Winzer PA; Imhof D; Müller J; Langa X; Rieder J; Barrett LK; Vidadala RSR; Huang W; Choi R; Hulverson MA; Whitman GR; Arnold SL; Van Voorhis WC; Ojo KK; Maly DJ; Fan E; Hemphill A
    Int J Antimicrob Agents; 2020 Sep; 56(3):106099. PubMed ID: 32707170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
    Manjunatha UH; Vinayak S; Zambriski JA; Chao AT; Sy T; Noble CG; Bonamy GMC; Kondreddi RR; Zou B; Gedeck P; Brooks CF; Herbert GT; Sateriale A; Tandel J; Noh S; Lakshminarayana SB; Lim SH; Goodman LB; Bodenreider C; Feng G; Zhang L; Blasco F; Wagner J; Leong FJ; Striepen B; Diagana TT
    Nature; 2017 Jun; 546(7658):376-380. PubMed ID: 28562588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats.
    Rehg JE
    J Parasitol; 1996 Feb; 82(1):158-62. PubMed ID: 8627487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
    Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.
    Gorla SK; McNair NN; Yang G; Gao S; Hu M; Jala VR; Haribabu B; Striepen B; Cuny GD; Mead JR; Hedstrom L
    Antimicrob Agents Chemother; 2014; 58(3):1603-14. PubMed ID: 24366728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.